Portfolio Design Labs LLC bought a new position in shares of Danaher Corporation (NYSE:DHR – Free Report) during the second quarter, HoldingsChannel reports. The fund bought 6,796 shares of the conglomerate’s stock, valued at approximately $1,295,000.
Other institutional investors also recently modified their holdings of the company. Reliant Investment Partners LLC bought a new position in shares of Danaher in the 2nd quarter valued at $369,000. Ninepoint Partners LP bought a new stake in Danaher during the 2nd quarter worth $1,542,000. Advisors Capital Management LLC acquired a new position in Danaher in the 2nd quarter worth about $1,877,000. MJP Associates Inc. ADV acquired a new position in Danaher in the 2nd quarter worth about $302,000. Finally, PCM Encore LLC bought a new position in Danaher in the second quarter valued at about $239,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.
Danaher Price Performance
Shares of NYSE DHR opened at $216.14 on Friday. The firm has a market capitalization of $151.94 billion, a P/E ratio of 38.39, a P/E/G ratio of 2.63 and a beta of 0.78. The firm’s 50-day moving average price is $195.01 and its 200-day moving average price is $192.43. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80.
Wall Street Analysts Forecast Growth
DHR has been the topic of a number of recent research reports. Piper Sandler initiated coverage on Danaher in a research note on Thursday, June 11th. They set a “neutral” rating and a $200.00 price target on the stock. TD Cowen dropped their price objective on shares of Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. Royal Bank Of Canada lifted their target price on shares of Danaher from $200.00 to $215.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 22nd. Wells Fargo & Company reduced their target price on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a report on Wednesday, July 22nd. Finally, Wolfe Research cut shares of Danaher from an “outperform” rating to a “peer perform” rating in a research report on Monday, June 1st. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and an average price target of $228.91.
Check Out Our Latest Stock Report on DHR
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
See Also
- Five stocks we like better than Danaher
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
